Liza Leshchiner

Liza Leshchiner is an accomplished scientist with a strong background in computational biology and immunology, currently serving as Associate Director and Principal Scientist II at AbbVie since 2024. Liza's expertise spans across various domains, including AI/ML applications in Discovery Immunology, Biotherapeutics, and Precision Medicine. Prior to AbbVie, Liza held multiple roles at the Broad Institute of MIT and Harvard from 2017 to 2025, including Group Leader, where leadership focused on analyzing drug responses and resistance in cancer, and Research Scientist roles contributing to collaborations with Bayer and significant cancer genome projects. As a Scientific Consultant for VC-backed biotech firms between 2020 and 2024, Liza provided critical insights that facilitated funding raises and drug target assessments. Liza's academic credentials include a Ph.D. from Harvard University and a M.S. from Moscow State University, along with research experience at prestigious institutions such as Dana-Farber Cancer Institute and MIT.